Previous 10 | Next 10 |
BioMarin Hires Industry Veterans to Fill Key Roles in R&D and Technical Operations BioMarin Hires Industry Veterans to Fill Key Roles in R&D and Technical Operations Harold S. Bernstein, M.D., Ph.D. Named Senior Vice President, Chief Medical Officer and Head of Clini...
Evercore ISI has set up its list of key catalysts for the rest of 2021 in the biotechnology sector - including early-stage data readouts as well as some important legal and regulatory updates ahead for particular companies. Along the way it tees up its rule of thumb on biotech catalysts: "Alw...
The TransCon platform is designed to optimize the delivery of known drugs to target tissues. The valuation of Ascendis Pharma is largely a reflection of the potential of the platform rather than a sum of the parts figure based on the current pipeline assets. This $9.5 B market cap...
The FDA has put on hold the BMN-307 trials due to the tumor detection in mice. My BMRN's price target was not affected by this news as I didn't include the possible BMN-307 sales in my forecast. I think a 70% chance of ValRox approval is sufficient to account for all current risks...
It might have been a mixed day for the broader averages, but AMC Entertainment (NYSE:AMC) had an unambiguously good session. No, this wasn't a result of meme-stock traders attempting to force another short squeeze -- at least, not completely. Rather, AMC shares reacted to actual positive...
Read the full story here: For further details see: Wall Street Breakfast: El Salvador Adopts Bitcoin (Podcast)
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Reddit targets BitcoinThe Bitcoin (BTC-USD) subreddit community is looking at a coordinated plan to buy the cryptocurrency to commemorate El Salvador's law...
U.S. FDA Placed a Clinical Hold on BMN 307 Phearless Phase 1/2 Gene Therapy Study in Adults with PKU Based on Interim Pre-clinical Study Findings BioMarin Also Pausing Further Enrollment of Additional Participants Outside the U.S. in Phearless Phase 1/2 Study BioMarin is Wor...
My actively managed Roth IRA portfolio (30 CEFs and 26 REITs for income, and 132 stocks for swing trading mostly S&P 500 stocks) continues to realize profits. In August, I closed 12 stock trades for a net gain, including dividends, of +41.5% (mean) or +38.2% (cost-weighted), for a...
European Commission Approves BioMarin's VOXZOGO® (vosoritide) for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close Achondroplasia is the Most Common Cause of Dwarfism First Medicine Approved to Treat Children with Achondroplasia in Euro...
News, Short Squeeze, Breakout and More Instantly...
BioMarin Pharmaceutical Inc. Company Name:
BMRN Stock Symbol:
NASDAQ Market:
BioMarin Pharmaceutical Inc. Website:
U.S. Food and Drug Administration Approves BioMarin's BRINEURA® (cerliponase alfa) for Children Under 3 Years with CLN2 Disease PR Newswire Now Approved for Children of All Ages with CLN2 Batten Disease, Regardless of Whether They Yet Show Symptoms SAN RAFAEL, C...
BioMarin to Host Second Quarter 2024 Financial Results Conference Call and Webcast on Monday, August 5, 2024, at 4:30pm ET PR Newswire SAN RAFAEL, Calif. , July 23, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander ...
2024-07-10 03:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...